GlassScriptPhysician profile
Matthew M Reichert
NPI 1477684405
$7,209.81
in general payments reported to CMS, 2019-2025
43 companies · $1,394 in 2025
The $1,394 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $871 · 2020: $676 · 2021: $454 · 2022: $1,114 · 2023: $1,248 · 2024: $1,452 · 2025: $1,394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,937 · Education: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,937.07 |
| Education | $156.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,058.07 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $946.62 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Insmed, INC. | $582.85 | 2019-2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $407.13 | 2019-2025 | Ofev, Jascayd, Spiriva Respimat |
| Grifols USA, LLC | $262.87 | 2020-2025 | Prolastin-C Liquid |
| Amgen INC. | $241.48 | 2023-2025 | Tezspire, Tavneos |
| Pfizer INC. | $222.60 | 2020-2024 | |
| Regeneron Healthcare Solutions, INC. | $178.66 | 2024-2025 | Dupixent |
| Philips North America LLC | $149.32 | 2020-2024 | (Ak6) Vest Therapy |
| Inari Medical, INC. | $146.63 | 2022 | |
| Tactile Systems Technology INC | $145.63 | 2024 | Flexitouch Plus, Entre Plus |
| Viatris Specialty LLC | $142.18 | 2025 | Yupelri |
| Axsome Therapeutics, INC. | $133.40 | 2025 | Sunosi |
| Genzyme Corporation | $133.33 | 2022-2024 | |
| Jazz Pharmaceuticals INC. | $119.01 | 2019-2024 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Reichert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.